Fenwick & West LLP represented DexCom, Inc. (NASDAQ: DXCM) in its recent Rule 144A offering of $60 million of Convertible Senior Notes due 2027 and in related issuer call spread options. DexCom, based in San Diego, CA, is a developer of glucose monitoring systems for people with diabetes.
More information about the transaction can be obtained from the DexCom Web site.
The Fenwick & West transaction team included corporate attorneys Robert Freedman, David Michaels, Gordy Davidson, John Lister, Pat Kelly and Scott Leichtner; and tax attorneys David Forst and Timothy Fitzgibbon.
Fenwick & West provides comprehensive legal services to technology and life sciences clients of national and international prominence. The firm is ranked by International Tax Review as one of only seven "First Tier" law firms in the entire U.S. and by MergerMarket as one of the top 5 technology M&A practices in the U.S., with #1 rankings in multiple quarters.